Clearmind Medicine Inc.(NASDAQ:CMND) 
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental heal...
Website: https://www.clearmindmedicine.com
Founded: 2017
IPO Price: $6.50 (Nov 15, 2022)
CEO: Adi Zuloff-Shani
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.02
H 1.04
L 1.00
C 1.03
V 40,621
10EMA 1.03
20EMA 1.03
60EMA 1.03
120EMA 1.03
250EMA 1.03